12 results · 30ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

FILTERWIRE EZ EMBOLIC PROTECTION SYSTEM (3.5 MM TO 5.5 MM)

FDA 510(k)
FDA Class 2 ·Cardiovascular

QUATRO M FEMORAL COMPONENT

FDA 510(k)
FDA Class 2 ·Orthopedic

FILAC FAS TEMP ELECTRONIC THERMOMETER

FDA 510(k)
FDA Class 2 ·General Hospital

STELLARIS VISION ENHANCEMENT SYSTEM

FDA Adverse Event
Injury ·BAUSCH + LOMB·Product code HQC·February 5, 2026

STELLARIS ELITE VISION ENHANCEMENT SYSTEM

FDA Adverse Event
Injury ·BAUSCH + LOMB·Product code HQC·March 1, 2022

LIBERTY CYCLER SET, SINGLE CONN/EXT DL

FDA Adverse Event
Malfunction ·REYNOSA MFG·Product code FKX·March 1, 2013

TAXUS (R) LIBERTÉ (R)

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC - MAPLE GROVE·Product code NIQ·April 19, 2011

PUMP MMT-722NAP PRDGM INS V2.2 PL EN

FDA Adverse Event
Injury ·MEDTRONIC PUERTO RICO OPERATONS MED-REL·Product code LZG·June 18, 2008

STELLARIS POWER SUPPLY II

FDA Adverse Event
Malfunction ·BAUSCH + LOMB·Product code HQC·August 1, 2023

KIT PERISAFE 18GA 3-1/2IN WEISS

FDA Adverse Event
Injury ·Product code CAZ·November 25, 2020

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

CADD¿- Solis Ambulatory Infusion Pump, Model 2111 & 2112, Version 1.0, Version 2.0 and Version 3.0 & Model 2120, Version 1.0. Provide measured drug therapy to patients in hospital or outpatient settings.

FDA Enforcement
Class II ·Terminated·Smiths Medical ASD, Inc.·June 24, 2015